Alivus Life Sciences Reports Record Financial Performance, Boosts Evaluation Score in May 2025

May 16 2025 08:55 AM IST
share
Share Via
Alivus Life Sciences has announced strong financial results for the quarter ending March 2025, achieving record quarterly net sales of Rs 649.55 crore and an operating profit of Rs 198.44 crore. The profit after tax reached Rs 141.87 crore, reflecting significant growth in earnings per share.
Alivus Life Sciences, a midcap player in the Pharmaceuticals & Biotechnology sector, has reported its financial results for the quarter ending March 2025, declaring them on May 15, 2025. The company has experienced notable financial performance during this period, with a significant adjustment in its evaluation score, rising to 10 from 4 over the last three months.

The financial data reveals that Alivus Life achieved its highest quarterly net sales in the last five quarters, amounting to Rs 649.55 crore. This positive trend is mirrored in the operating profit, which also reached a peak of Rs 198.44 crore, indicating enhanced operational efficiency with an operating profit margin of 30.55%.

Additionally, the profit before tax (PBT) stood at Rs 181.20 crore, reflecting a growth of 28.3% compared to the average of the previous four quarters. The profit after tax (PAT) also reached a record high of Rs 141.87 crore, with a growth rate of 28.5% over the same comparative period. Furthermore, earnings per share (EPS) hit Rs 11.58, showcasing the company's ability to generate higher earnings for its shareholders.

Overall, Alivus Life Sciences has demonstrated strong financial metrics in this quarter, leading to a revision in its score.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
Why is Chandan Healthca falling/rising?
24 minutes ago
share
Share Via
Why is KRN Heat Exchan falling/rising?
24 minutes ago
share
Share Via
Why is Solarium Green falling/rising?
24 minutes ago
share
Share Via
Why is Gajanand Inter. falling/rising?
24 minutes ago
share
Share Via
Why is Sahasra Electro. falling/rising?
24 minutes ago
share
Share Via
Why is Globale Tessile falling/rising?
25 minutes ago
share
Share Via
Why is AWFIS Space falling/rising?
25 minutes ago
share
Share Via